6Stephen J. Nicholls, MBBS, PhD,E. Murat Tuzcu, MD,IIke Sipahi, MD,Adam W. Grasso, MD,Paul Schoenhagen, MD,Tingfei Hu, MS,Kathy Wolski, MPH,Tim Crowe, BS,Milind Y. Desai, MD,Stanley L. Hazen, MD, PhD,Samir R. Kapadia, MD,Steven E. Nissen, MD,李呈亿（译）.他汀、高密度脂蛋白胆固醇与冠状动脉粥样硬化消退[J].美国医学会杂志（中文版）,2007,26(3):152-160. 被引量：48
7[1]Wilson PW,Abbott RD,Castelli WP et al High density lipoprotein cholesterol and mortality.The Framingham Heart study[J].Arteriosclerosis,1998,8(4):737～741.
8[3]Rajesh M,Daniel JR.Laboratory assessment of HDL heterogenicity and function[J].Clin Chem,2008,54(5):788～800.
9[4]Gordon T,Castelli WP,Hjortland MC et al High density lipoprotein as a protective factor agaist coronary heart disease[J].Am J Med,1997,62:707～714.
10[5]Brousseau ME,Shader EL,Wolfe ML,et al.Effects of an inhibitor of choleateryl ester trasfer protein on HDL cholesterol[J].N Engl J Med,2004,350;1505～1515.
3Wang Y, Cheng KK, Lam KS, et al. APPL1 counteracts obesity- induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothe- lin-1 in mice. Diabetes, 2011,60 ( 11 ) : 3044-3054. doi: 10.2337/db11-0666.
4Jung CH, Lee WJ, Hwang JY, et al. Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylargin- ine in vascular endothelial cells. PLoS One, 2012, 7 ( 12 ) : e52346, doi: 10. 1371/journal. pone. 0052346.
5Sanchetee P, Venkataraman S, Mohan C, et al. Basal ganglia cal- cification[J]. J Assoc Physicians India, 1999,47 (5) :507-509.
6Ostling S, Andreasson LA, Skoog I. Basal ganglia calcification and psychotic symptoms in the very old[J]. Int J Geriatr Psychiatry, 2003,18 (11) : 983-987.
7Koller WC, Cochran JW, Klawans HL. Calcification of the basal ganglia:computerized tomography and clinical correlation[J]. Neurology, 1979,29 (3) : 328-333.
